Olsen, R. W. & Sieghart, W. International Union of Pharmacology. LXX. Subtypes of γ-aminobutyric acidA receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol. Rev. 60, 243–260 (2008).
Sieghart, W. & Savic, M. M. International Union of Basic and Clinical Pharmacology. CVI: GABAA receptor subtype- and function-selective ligands: key issues in translation to humans. Pharmacol. Rev. 70, 836–878 (2018).
Olsen, R. W. & Sieghart, W. GABAA receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology 56, 141–148 (2009).
Kim, J. J. & Hibbs, R. E. Direct structural insights into GABAA receptor pharmacology. Trends Biochem. Sci. 46, 502–517 (2021).
Sente, A. et al. Differential assembly diversifies GABAA receptor structures and signalling. Nature 604, 190–194 (2022).
Kasaragod, V. B. et al. The molecular basis of drug selectivity for alpha5 subunit-containing GABAA receptors. Nat. Struct. Mol. Biol. 30, 1936–1946 (2023).
Cowgill, J. et al. Structure and dynamics of differential ligand binding in the human rho-type GABAA receptor. Neuron 111, 3450–3464.e3455 (2023).
Sun, C., Zhu, H., Clark, S. & Gouaux, E. Cryo-EM structures reveal native GABAA receptor assemblies and pharmacology. Nature 622, 195–201 (2023).
Nutt, D. GABAA receptors: subtypes, regional distribution, and function. J. Clin. Sleep Med. 2, S7–S11 (2006).
Chuang, S. H. & Reddy, D. S. Genetic and molecular regulation of extrasynaptic GABAA receptors in the brain: therapeutic insights for epilepsy. J. Pharmacol. Exp. Ther. 364, 180–197 (2018).
Sigel, E. & Steinmann, M. E. Structure, function, and modulation of GABAA receptors. J. Biol. Chem. 287, 40224–40231 (2012).
Mihic, S. J. & Harris, R. A. GABA and the GABAA receptor. Alcohol Health Res, World 21, 127–131 (1997).
Pirker, S., Schwarzer, C., Wieselthaler, A., Sieghart, W. & Sperk, G. GABAA receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 101, 815–850 (2000).
Loup, F. et al. A highly sensitive immunofluorescence procedure for analyzing the subcellular distribution of GABAA receptor subunits in the human brain. J. Histochem. Cytochem. 46, 1129–1139 (1998).
Sperk, G. et al. Immunohistochemical distribution of 10 GABAA receptor subunits in the forebrain of the rhesus monkey Macaca mulatta. J. Comp. Neurol. 528, 2551–2568 (2020).
Stefanits, H. et al. GABAA receptor subunits in the human amygdala and hippocampus: Immunohistochemical distribution of 7 subunits. J. Comp. Neurol. 526, 324–348 (2018).
Martenson, J. S., Yamasaki, T., Chaudhury, N. H., Albrecht, C. & Tomita, S. Assembly rules for GABAA receptor complexes in the brain. eLife 6, e27443 (2017).
Zhang, C. et al. Neurexins physically and functionally interact with GABAA receptors. Neuron 66, 403–416 (2010).
Liu, Y. T. et al. Mesophasic organization of GABAA receptors in hippocampal inhibitory synapses. Nat. Neurosci. 23, 1589–1596 (2020).
Tretter, V. et al. Gephyrin, the enigmatic organizer at GABAergic synapses. Front. Cell Neurosci. 6, 23 (2012).
Spencer, D. & Burchiel, K. Selective amygdalohippocampectomy. Epilepsy Res. Treat. 2012, 382095 (2012).
Zhu, S. et al. Structure of a human synaptic GABAA receptor. Nature 559, 67–72 (2018).
Yamasaki, T., Hoyos-Ramirez, E., Martenson, J. S., Morimoto-Tomita, M. & Tomita, S. GARLH family proteins stabilize GABAA receptors at synapses. Neuron 93, 1138–1152.e1136 (2017).
Bencsits, E., Ebert, V., Tretter, V. & Sieghart, W. A significant part of native γ-aminobutyric acidA receptors containing α4 subunits do not contain γ or δ subunits. J. Biol. Chem. 274, 19613–19616 (1999).
Benke, D. et al. Analysis of the presence and abundance of GABAA receptors containing two different types of α subunits in murine brain using point-mutated α subunits. J. Biol. Chem. 279, 43654–43660 (2004).
Mertens, S., Benke, D. & Mohler, H. GABAA receptor populations with novel subunit combinations and drug binding profiles identified in brain by α5- and δ-subunit-specific immunopurification. J. Biol. Chem. 268, 5965–5973 (1993).
Scholze, P. et al. Two distinct populations of α1α6-containing GABAA-receptors in rat cerebellum. Front. Synaptic Neurosci. 12, 591129 (2020).
Zhang, S. et al. One-step construction of circularized nanodiscs using SpyCatcher–SpyTag. Nat. Commun. 12, 5451 (2021).
Dalal, V. et al. Lipid nanodisc scaffold and size alter the structure of a pentameric ligand-gated ion channel. Nat. Commun. 15, 25 (2024).
Engin, E., Liu, J. & Rudolph, U. alpha2-containing GABAA receptors: a target for the development of novel treatment strategies for CNS disorders. Pharmacol. Ther. 136, 142–152 (2012).
Nguyen, Q. A. & Nicoll, R. A. The GABAA receptor β subunit is required for inhibitory transmission. Neuron 98, 718–725 e713 (2018).
Jensen, M. L. et al. The β subunit determines the ion selectivity of the GABAA receptor. J. Biol. Chem. 277, 41438–41447 (2002).
Uygun, D. S. et al. Knockdown of GABAA α3 subunits on thalamic reticular neurons enhances deep sleep in mice. Nat. Commun. 13, 2246 (2022).
Dias, R. et al. Evidence for a significant role of α3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines. J. Neurosci. 25, 10682–10688 (2005).
Saras, A. et al. Histamine action on vertebrate GABAA receptors: direct channel gating and potentiation of GABA responses. J. Biol. Chem. 283, 10470–10475 (2008).
Sigel, E. & Ernst, M. The benzodiazepine binding sites of GABAA receptors. Trends Pharmacol. Sci. 39, 659–671 (2018).
Kim, J. J. et al. Shared structural mechanisms of general anaesthetics and benzodiazepines. Nature 585, 303–308 (2020).
Masiulis, S. et al. GABAA receptor signalling mechanisms revealed by structural pharmacology. Nature 565, 454–459 (2019).
Zhu, S. et al. Structural and dynamic mechanisms of GABAA receptor modulators with opposing activities. Nat. Commun. 13, 4582 (2022).
Ramerstorfer, J. et al. The GABAA receptor α+β− interface: a novel target for subtype selective drugs. J. Neurosci. 31, 870–877 (2011).
Varagic, Z. et al. Identification of novel positive allosteric modulators and null modulators at the GABAA receptor α+β− interface. Br. J. Pharmacol. 169, 371–383 (2013).
Mortensen, M. et al. Forty Years searching for neurosteroid binding sites on GABAA receptors. Neuroscience https://doi.org/10.1016/j.neuroscience.2024.06.002 (2024).
Legesse, D. H. et al. Structural insights into opposing actions of neurosteroids on GABAA receptors. Nat. Commun. 14, 5091 (2023).
Tonon, M. C. et al. Endozepines and their receptors: structure, functions and pathophysiological significance. Pharmacol. Ther. 208, 107386 (2020).
Bormann, J. Electrophysiological characterization of diazepam binding inhibitor (DBI) on GABAA receptors. Neuropharmacology 30, 1387–1389 (1991).
Everlien, I. et al. Diazepam binding inhibitor governs neurogenesis of excitatory and inhibitory neurons during embryonic development via GABA signaling. Neuron 110, 3139–3153.e3136 (2022).
Sanchez, J. D., Gomez-Carpintero, J., Gonzalez, J. F. & Menendez, J. C. Twenty-first century antiepileptic drugs. An overview of their targets and synthetic approaches. Eur. J. Med. Chem. 272, 116476 (2024).
Devenish, S. O. et al. The anticonvulsant zonisamide positively modulates recombinant and native glycine receptors at clinically relevant concentrations. Neuropharmacology 182, 108371 (2021).
Liu, L. et al. The mechanism of carbamazepine aggravation of absence seizures. J. Pharmacol. Exp. Ther. 319, 790–798 (2006).
Zheng, T. et al. Oxcarbazepine, not its active metabolite, potentiates GABAA activation and aggravates absence seizures. Epilepsia 50, 83–87 (2009).
Hammer, H., Ebert, B., Jensen, H. S. & Jensen, A. A. Functional characterization of the 1,5-benzodiazepine clobazam and its major active metabolite N-desmethylclobazam at human GABAA receptors expressed in Xenopus laevis oocytes. PLoS ONE 10, e0120239 (2015).
Gauthier, A. C. & Mattson, R. H. Clobazam: a safe, efficacious, and newly rediscovered therapeutic for epilepsy. CNS Neurosci. Ther. 21, 543–548 (2015).
Reimers, A. et al. Reference ranges for antiepileptic drugs revisited: a practical approach to establish national guidelines. Drug Des. Dev. Ther. 12, 271–280 (2018).
Tomita, S. Molecular constituents and localization of the ionotropic GABA receptor complex in vivo. Curr. Opin. Neurobiol. 57, 81–86 (2019).
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).
Ge, J. et al. Structure of mouse protocadherin 15 of the stereocilia tip link in complex with LHFPL5. eLife 7, e38770 (2018).
Skolnick, P. Anxioselective anxiolytics: on a quest for the Holy Grail. Trends Pharmacol. Sci. 33, 611–620 (2012).
Pandya, M. et al. Sex- and age-related changes in GABA signaling components in the human cortex. Biol. Sex Differ. 10, 5 (2019).
Ethiraj, J. et al. The effect of age and sex on the expression of GABA signaling components in the human hippocampus and entorhinal cortex. Sci Rep. 11, 21470 (2021).
Chameh, H. M. et al. Distinctive biophysical features of human cell-types: insights from studies of neurosurgically resected brain tissue. Front. Synaptic Neurosci. 15, 1250834 (2023).
Engin, E. GABAA receptor subtypes and benzodiazepine use, misuse, and abuse. Front. Psychiatry 13, 1060949 (2022).
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70–82 (2021).
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486–501 (2010).
Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D 74, 531–544 (2018).
Williams, C. J. et al. MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci. 27, 293–315 (2018).
Smart, O. S., Neduvelil, J. G., Wang, X., Wallace, B. A. & Sansom, M. S. HOLE: a program for the analysis of the pore dimensions of ion channel structural models. J. Mol. Graph. 14, 354–360, 376 (1996).
Shevchenko, A., Wilm, M., Vorm, O. & Mann, M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68, 850–858 (1996).
Chojnacka, W., Teng, J., Kim, J. J., Jensen, A. A. & Hibbs, R. E. Structural insights into GABAA receptor potentiation by Quaalude. Nat. Commun. 15, 5244 (2024).
Kowarz, E., Loscher, D. & Marschalek, R. Optimized Sleeping Beauty transposons rapidly generate stable transgenic cell lines. Biotechnol. J. 10, 647–653 (2015).
Mates, L. et al. Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat. Genet. 41, 753–761 (2009).
Smart, O.S. et al. Grade2 v.1.6.0. (Global Phasing Ltd., 2021).
Laverty, D. et al. Cryo-EM structure of the human α1β3γ2 GABAA receptor in a lipid bilayer. Nature 565, 516–520 (2019).
